Clinical Trials Logo

Clinical Trial Summary

Implantable collamer lens (ICL) is one of the most effective operation for high myopia. Due to refractive correction changed, and prism effect of the spectacle removed, in the early stage after ICL implantation, binocular function might be dysfunction, leading to asthenopia, blurred vision, double vision and so on. This study will recruit the high myopia subjects that scheduled for ICL implantation, purpose to investigate the binocular vision alternations and brain activation that impacted by ICL implantation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05633212
Study type Observational
Source Zhongshan Ophthalmic Center, Sun Yat-sen University
Contact Yehong Zhuo, doctor
Phone 13352828998
Email zhuoyh@mail.sysu.edu.cn
Status Recruiting
Phase
Start date March 15, 2022
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05208658 - Characteristics of the Vergence Responses of Binocularly Normal Subjects After a Vision Therapy Protocol N/A
Completed NCT05070767 - Neurolens Headache Study N/A
Terminated NCT05087563 - Neurolens Convergence Insufficiency Study N/A
Not yet recruiting NCT05522595 - Performance and Safety Evaluation of the S360 Medical Device Software. N/A
Active, not recruiting NCT00338611 - Convergence Insufficiency Treatment Trial (CITT) Phase 3
Enrolling by invitation NCT03603301 - Vision in Children Born to Opioid-dependent Methadone-maintained Mothers
Completed NCT03592615 - Binocular Vision Anomalies After Cataract and Refractive Surgery N/A
Completed NCT04086524 - A Patch Free Treatment for Young Children With Amblyopia N/A
Completed NCT02651389 - Evaluation of Tests Performance on a New Digital Orthoptic Platform N/A